Circulating Plasma Micro RNAs in Patients with Major Depressive Disorder Treated with Antidepressants: A Pilot Study

키워드

참고문헌 (52)

1. Kessler RC, "Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication", Arch Gen Psychiatry, 62, pp.593~602 (2005)
2. Murray CJL, "Alternative projections of mortality and disability by cause 1990-2020 : Global Burden of Disease Study", Lancet, 349, pp.1498~1504 (1997)
3. Laursen TM, "A comparison of selected risk factors for unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia from a danish population-based cohort", J Clin Psychiatry, 68, pp.1673~1681 (2007)
4. Thase ME, "Remission with venlafaxine extended release or selective serotonin reuptake inhibitors in depressed patients: a randomized, open-label study", Prim Care Companion CNS Disord, 13 (2011)
5. Ota KT, "Environmental and pharmacological modulations of cellular plasticity : role in the pathophysiology and treatment of depression", Neurobiol Dis, 57, pp.28~37 (2013)
6. Aganova EA, "Morphometric analysis of synaptic contacts in the anterior limbic cortex in the endogenous psychoses", Neurosci Behav Physiol, 22, pp.59~65 (1992)
7. Dolan RJ, "Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity?", J Neurol Neurosurg Psychiatry, 56, pp.1290~1294 (1993)
8. Drevets WC, "Reduced glucose metabolism in the subgenual prefrontal cortex in unipolar depression", Mol Psychiatry, 3, pp.190~191 (1998)
9. Andreasen NC, "Linking mind and brain in the study of mental illnesses : a project for a scientific psychopathology", Science, 275, pp.1586~1593 (1997)
10. Honer WG, "Assessing the machinery of mind : synapses in neuropsychiatric disorders", J Psychiatry Neurosci, 24, pp.116~121 (1999)
11. Toni N, "LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite", Nature, 402, pp.421~425 (1999)
12. Hajsza T, "Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus", Eur J Neurosci, 21, pp.1299~1303 (2005)
13. McEwen BS, "Effects of adverse experiences for brain structure and function", Biol Psychiatry, 48, pp.721~731 (2000)
14. Sheline YI, "3D MRI studies of neuroanatomic changes in unipolar major depression : the role of stress and medical comorbidity", Biol Psychiatry, 48, pp.791~800 (2000)
15. Sala M, "Stress and hippocampal abnormalities in psychiatric disorders", Eur Neuropsychopharmacol, 14, pp.393~405 (2004)
16. Rajkowska G, "Gliogenesis and glial pathology in depression", CNS Neurol Disord Drug Targets, 6, pp.219~233 (2007)
17. Stefani G, "Small non-coding RNAs in animal development", Nat Rev Mol Cell Biol, 9, pp.219~230 (2008)
18. Serafini G, "The involvement of microRNAs in major depression, suicidal behavior, and related disorders: a focus on miR-185 and miR-491-3p", Cell Mol Neurobiol, 34, pp.17~30 (2014)
19. Barry G, "Integrating the roles of long and small non-coding RNA in brain function and disease", Mol Psychiatry, 19, pp.410~416 (2014)
20. Adlakha YK, "Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128", Mol Cancer, 13, pp.33~ (2014)
21. Dwivedi Y, "Emerging role of microRNAs in major depressive disorder : diagnosis and therapeutic implications", Dialogues Clin Neurosci, 16, pp.43~61 (2014)
22. Im HI, "MicroRNAs in neuronal function and dysfunction", Trends Neurosci, 35, pp.325~334 (2012)
23. Malphettes L, "Impact of RNA interference on gene networks", Metab Eng, 8, pp.672~683 (2006)
24. Smalheiser NR, "MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects", PLoS One, 7, pp.e33201~ (2012)
25. Lopez JP, "miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment", Nat Med, 20, pp.764~768 (2014)
26. Baudry A, "miR-16 targets the serotonin transporter : a new facet for adaptive responses to antidepressants", Science, 329, pp.1537~1541 (2010)
27. O’Connor RM, "microRNAs as novel antidepressant targets : converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus", Int J Neuropsychopharmacol, 16, pp.1885~1892 (2013)
28. Witwer KW, "Circulating MicroRNA Biomarker Studies : Pitfalls and Potential Solutions", Clin Chem, 61, pp.56~63 (2015)
29. Weber JA, "The microRNA spectrum in 12 body fluids", Clin Chem, 56, pp.1733~1741 (2010)
30. Fan HM, "Differential expression of microRNA in peripheral blood mononuclear cells as specific biomarker for major depressive disorder patients", J Psychiatr Res, 59, pp.45~52 (2014)
31. Wan Y, "Identification of differential microRNAs in cerebrospinal fluid and serum of patients with major depressive disorder", PLoS One, 10, pp.e0121975~ (2015)
32. Belzeaux R, "Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode", Transl Psychiatry, 2, pp.e185~ (2012)
33. Bocchio-Chiavetto L, "Blood microRNA changes in depressed patients during antidepressant treatment", Eur Neuropsychopharmacol, 23, pp.602~611 (2013)
34. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" (2000), American Psychiatric Association
35. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research version (SCID-I RV), "First MB", Biometrics Research, ~ (2002)
36. Hamilton M, "Development of a rating scale for primary depressive illness", Br J Soc Clin Psychol, 6, pp.278~296 (1967)
37. Lam RW, "Assessment Scales in Depression, Mania and Anxiety" (2005), Taylor and Francis
38. Kroh EM, "Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR(qRT-PCR)", Methods, 50, pp.298~301 (2010)
39. Dweep H, "miRWalk-database : prediction of possible miRNA binding sites by"walking"the genes of 3 genomes", J Biomed Inform, 44, pp.839~847 (2011)
40. Smalheiser NR, "MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects", PLoS One, 7, pp.e33201~ (2012)
41. Zhou R, "Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers", Neuropsychopharmacology, 34, pp.1395~1405 (2009)
42. Rinaldi A, "Stress induces region specific alterations in microRNAs expression in mice", Behav Brain Res, 208, pp.265~269 (2010)
43. Mundalil Vasu M, "Serum microRNA profiles in children with autism", Mol Autism, 5, pp.40~ (2014)
44. Shi W, "Aberrant expression of serum miRNAs in schizophrenia", J Psychiatr Res, 46, pp.198~204 (2012)
45. Miguel C, "Drug interaction in psycho-oncology : antidepressants and antineoplastics", Pharmacology, 88, pp.333~339 (2011)
46. Oved K, "Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers", Pharmacogenomics, 13, pp.1129~1139 (2012)
47. Oved K, "Genome-wide expression profiling of human lymphoblastoid cell lines implicates integrin beta-3 in the mode of action of antidepressants", Transl Psychiatry, 3, pp.e313~ (2013)
48. Duric V, "A negative regulator of MAP kinase causes depressive behavior", Nat Med, 16, pp.1328~1332 (2010)
49. Karege F, "Protein levels of β-catenin and activation state of glycogen synthase kinase-3β in major depression. A study with postmortem prefrontal cortex", J Affect Disord, 136, pp.185~188 (2012)
50. Liu R, "Citalopram alleviates chronic stress induced depression-like behaviors in rats by activating GSK3β signaling in dorsal hippocampus", Brain Res, 1467, pp.10~17 (2012)
51. Lau T, "Antidepressant-induced internalization of the serotonin transporter in serotonergic neurons", FASEB J, 22, pp.1702~1714 (2008)
52. Bonnin A, "The SSRI citalopram affects fetal thalamic axon responsiveness to netrin-1 in vitro independently of SERT antagonism", Neuropsychopharmacology, 37, pp.1879~1884 (2012)

관련 논문AI추천